UnitedHealth
At a Glance
- Revenue down slightly; EBIDTA up $400M
- Early price increase in quarter, followed by significant drop
Rolling 12 months financials
Year over year financials
Stock Performance
MA = moving average; GSPC = S&P 500
Analyst buy/sell recommendations
Insider sentiment for quarter- Negative
Based on trading behaviors of company officers and directors trading in their own stock
Earnings Call Summary
No call transcript available at time of writing
Other indicators
Innovation score - Outperforming sector
Based on R&D activities.
Deeper reading
END OF REPORT
